Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,529,788
-
Share change
-
-86,511
-
Total reported value
-
$40,435,912
-
Price per share
-
$3.84
-
Number of holders
-
30
-
Value change
-
-$429,782
-
Number of buys
-
9
-
Number of sells
-
16
Institutional Holders of TENAX THERAPEUTICS INC - COM (TENX) as of Q4 2014
As of 31 Dec 2014,
TENAX THERAPEUTICS INC - COM (TENX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,529,788 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, Broadfin Capital, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Opaleye Management Inc., Opus Point Partners Management, LLC, DEUTSCHE BANK AG\, Bank of New York Mellon Corp, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.